Transaction in Own Shares

Summary by AI BETAClose X

On August 28, 2025, GSK plc announced the purchase of 260,986 of its own ordinary shares, each with a nominal value of 31¼ pence, on August 27, 2025. The shares were bought through Merrill Lynch International, GSK's corporate stockbroker. The lowest price paid per share was 1,471.00 GBp, while the highest price was 1,484.00 GBp, with a volume-weighted average price of 1,477.76 GBp. These shares will be held as Treasury shares as part of an existing buyback program. Since June 4, 2025, GSK has purchased 25,785,333 ordinary shares. Following this purchase, GSK holds 243,919,716 ordinary shares in treasury, with 4,071,472,911 ordinary shares in issue, excluding treasury shares; the percentage of voting rights attributable to treasury shares is 5.99 percent.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings